Alzheimer’s Disease is among the common illnesses that plague the elderly. New studies show that Alzheimer’s Disease can already be predicted decades before symptoms of the illness develop.
As told by the Daily Mail, scientists from the University of California conducted a study that can predict the presence of the disease through a brain scan. The brain scan can identify a kind of brain wave, referred to as a Sharp Wave Ripple or SWR. This type of brain wave plays a big part in a person’s spatial learning as well as memory formation.
The scientists conducted this study on lab rodents. They found that the rodents who lacked this particular brain wave did not fare well in memory tests after 10 months which is equivalent to 30 human years. This may also serve as an early indicator of dementia in humans.
Dr. Emily Jones, the senior author of the study, however, revealed that while they are not “betting on these results,” the fact that young mice who do not have memory problems already have an indicator of it this early is still a sign. Fellow senior author Dr. Yadong Huang said that the advantage in this approach is that it is a non-invasive method in predicting Alzheimer’s disease decades before the illness develops in a person.
Another study conducted by researchers from the Washington School of Medicine reveals that Alzheimer’s disease can be predicted decades before the disease develops through a blood test. According to The Guardian, the scientists claim that the blood test can predict the changes in a person’s brain activity with an accuracy rating of 94 percent.
The researchers published their findings on the Neurology journal, the study in itself representing another possible breakthrough when it comes to developing a cure as well as early prevention of the debilitating disease.
The blood test involves identifying the levels of a particular protein, called the amyloid-beta, in a person. The levels of amyloid-beta are what can indicate how much of this protein has accumulated in the brain. The clusters of this protein start forming up to 20 years in advance before the start of the usual memory loss.
Randall Bateman, a Neurology professor as well as one of the study’s senior authors, says that they are currently screening people for clinical trials with the usual brain scans. However, brain scans are also expensive and are time-consuming and enrolling participants alone can take years at a time. Bateman adds that through blood testing, they can screen twice or thrice the number of people in a month.
The major downside to this study is that the benefits gained from the testing cannot be achieved until a cure to stop Alzheimer’s disease is developed.
Whichever the case, both studies seem to be able to indicate that Alzheimer’s disease can be predicted decades before the symptoms develop. Although there has yet to be a solid cure for the neurological disease, the studies conducted are still a step forward in developing a way to fight Alzheimer’s disease.


Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
U.S. Issues Cuba Health Alert as Illnesses Rise
France Keeps Top Health Alert as Officials Brace for Another Heatwave
FDA Weighs Safety Standards for Psychedelic Therapies 



